‹ All Posts
RAJIV GUPTA (SEBI RA)

12th Mar · SEBI-Registered Analyst

Announces Buyback - Jagsonpal Pharmaceuticals Ltd

Code BSE: 507789 NSE:

JAGSNPHARM
a) Buyback price of Rs 250, a premium of 40% to current market price b) Buyback of up to 16 lakh equity shares for a total consideration of Rs 40 crores c) Promoters not to participate in the Buyback The proposed buyback demonstrates the company’s continued commitment to enhancing shareholder value and optimizing its capital structure. This isintended to reward shareholders and is expected to improve key metrics including earnings per share and return on capital employed, while maintaining sufficient capital to support the company’s ongoing growth initiatives including exploring inorganic initiatives.

#WatchOutFor#StockInNews
JAGSONPAL12032026.pdf
530 likes·53 comments